Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $360.86B · View financials
Decision snapshot: CPRX stock price vs AMAT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMAT's multiple
Needs AMAT P/E.
Implied fair value · at CPRX's multiple
Needs CPRX P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CPRX FY 2025 (ended Dec 31, 2025) · AMAT FY 2025 (ended Oct 26, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 98% equity / 2% debt · EV / Revenue 12.65x · EV / EBITDA 36.25x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CATALYST PHARMACEUTICALS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
APPLIED MATERIALS INC /DE · implied price per share
Bear
$120.65
Base
$147.28
Bull
$167.98
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.15x
0.32x
Net debt / EBITDA
Leverage against operating earnings
-1.75x
-0.20x
Cash and equivalents
Liquid reserves on the balance sheet
$709.17M
$8.57B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Jazz Pharmaceuticals plc
CPRX vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
CPRX vs SUPN
PERRIGO Co plc
CPRX vs PRGO
Harmony Biosciences Holdings, Inc.
CPRX vs HRMY
LAM RESEARCH CORP
CPRX vs LRCX
ASML HOLDING NV
CPRX vs ASML
TERADYNE, INC
CPRX vs TER
MKS INSTRUMENTS INC
CPRX vs MKSI
KLA CORP
CPRX vs KLAC
SKYWORKS SOLUTIONS, INC.
CPRX vs SWKS
$145.25M
$6.56B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
